For Registraion of Drugs, Medical Devices, Vaccines, Food Addetive, and Pesticides
By
Ph.D., DBAT
M.V.Sc., Ph.D., DABT–Subject Matter Expert
M.V.Sc., Ph.D., DABT–Subject Matter Expert
Dr. K. S. Rao, M.V.Sc., Ph.D., DABT, is a renowned figure in the field of toxicology and regulatory sciences. With decades of experience, Dr. Rao has been instrumental in advancing toxicology research and education in India.
Ph.D., DBAT
With 56 books and dozens of publications to his name, Dr. Gad is a titan in the field of toxicology. His seminars have educated professionals worldwide, and this workshop marks the debut of his latest curriculum.
Under the leadership of Dr. K. S. Rao, M.V.Sc., Ph.D., DABT, is thrilled to announce a groundbreaking workshop led by the legendary Dr. Shayne C. Gad, a global authority in toxicology with over 50 years of unparalleled experience. This exclusive event, the first of its kind in India, will take place from April 21st to 23rd, 2025, in Chandigarh, and will also be available virtually for global participants.
Regulatory Toxicology is the backbone of product development across pharmaceuticals, medical devices, pesticides, food additives, and more. This workshop is designed to provide cutting-edge knowledge and real-world insights that are not taught in any university or college. Dr. Gad, with his unmatched expertise and engaging teaching style, will deliver brand-new syllabus presentations that are exclusive to this event.
First-Time Topics in India: Dr. Gad will cover advanced regulatory aspects of emerging medical products like Monoclonal Antibodies, Oligonucleotides, Antisense Nucleotides (ASOs), and Cell and Gene Therapy Safety Assessment. These areas represent nearly 60% of drugs under development today.
Real-Life Case Studies: Learn from unpublished, real-life examples in Medical Devices, Pesticides, Food Additives, Nutraceuticals, Excipients, and Vaccines.
Indian Pharma Focus: Special sessions on Indian CRO Landscape and Opportunities for Global Market Expansion and Nitrosamine Risk Assessment in Drug Products will address current challenges and opportunities in the Indian pharmaceutical industry.
Combination Drug Products and Complex Generics: For the first time, Dr. Gad will present on Regulatory Strategy for Combination Drug Products and Complex Generic Drug Development, a topic rarely covered in any publication.
We are proud to be sponsors of this pioneering workshop, supporting the advancement of regulatory toxicology and fostering innovation in the pharmaceutical and life sciences industries. Join us in this transformative event to shape the future of toxicology and regulatory compliance.
